Regulatory and criminal investigations into companies and their
management are a growing source of exposure for both those involved
in the investigation and their D&O insurers. This key topic was
the subject of a BLG seminar to the London Market on 7 July
2010.
In this edition of the D&O Review we summarise the main
issues addressed by the speakers as well as a few other recent
developments of interest.
Background
Following the decision of the US Supreme Court in
Morrison v National Australia Bank that
"foreign-cubed" cases are no longer welcome in the US
courts, the exposure of non-US companies to civil shareholder
securities claims has arguably been curtailed. However, in our
practice we are seeing a marked increase in severity and frequency
of criminal and regulatory investigations for which D&O
insurers will pick up the costs. This is perhaps not surprising. In
response to public pressure following the worldwide financial
crisis, regulatory agencies